Association Between the Presence of Coronary Artery Disease or Peripheral Artery Disease and Left Ventricular Mass in Patients Who Have Undergone Coronary Computed Tomography Angiography.
Computed tomography angiography
Coronary artery disease
Left ventricular hypertrophy
Peripheral artery disease
Journal
Cardiology research
ISSN: 1923-2829
Titre abrégé: Cardiol Res
Pays: Canada
ID NLM: 101557543
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
26
06
2023
accepted:
09
08
2023
medline:
8
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
ppublish
Résumé
Left ventricular mass (LVM) is a critical marker of future cardiovascular risk. We determined the association between LVM measured by coronary computed tomography angiography (CCTA) and the presence of coronary artery disease (CAD) or peripheral artery disease (PAD) in patients who had undergone CCTA for screening of CAD. We enrolled 1,307 consecutive patients (66 ± 12 years old, 49% males) who underwent CCTA for screening of CAD at the Fukuoka University Hospital (FU-CCTA registry), and either were clinically suspected of having CAD or had at least one cardiovascular risk factor. Patients with coronary stenosis of ≥ 50% by CCTA were diagnosed as CAD. Patients with an ankle brachial pressure index < 0.9 or who had already been diagnosed with PAD were considered to have PAD. Left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF), end-diastolic volume (EDV) and end-systolic volume (ESV) were measured. The patients were divided into CAD (-) and CAD (+) or PAD (-) and PAD (+) groups. The prevalences of CAD and PAD in all patients were 50% and 4.8%, respectively. Age, %males, %hypertension (HTN), %dyslipidemia (DL), %diabetes mellitus (DM), %smoking and %chronic kidney disease in the CAD (+) group were significantly higher than those in the CAD (-) group. Age, %males, %HTN, %DM and %smoking in the PAD (+) group were significantly higher than those in the PAD (-) group. CAD was independently associated with LVMI (odds ratio (OR): 1.01, 95% confidence interval (CI): 1.01 - 1.02, P < 0.01) in addition to age, male, HTN, DL, DM, and smoking. PAD was also independently associated with LVMI (OR: 1.01, 95% CI: 1.0 - 1.02, P = 0.018) in addition to age, DM, and smoking. LVMI determined by CCTA may be useful for predicting atherosclerotic cardiovascular diseases including both CAD and PAD, although there were considerable differences between %CAD and %PAD in all patients.
Sections du résumé
Background
UNASSIGNED
Left ventricular mass (LVM) is a critical marker of future cardiovascular risk. We determined the association between LVM measured by coronary computed tomography angiography (CCTA) and the presence of coronary artery disease (CAD) or peripheral artery disease (PAD) in patients who had undergone CCTA for screening of CAD.
Methods
UNASSIGNED
We enrolled 1,307 consecutive patients (66 ± 12 years old, 49% males) who underwent CCTA for screening of CAD at the Fukuoka University Hospital (FU-CCTA registry), and either were clinically suspected of having CAD or had at least one cardiovascular risk factor. Patients with coronary stenosis of ≥ 50% by CCTA were diagnosed as CAD. Patients with an ankle brachial pressure index < 0.9 or who had already been diagnosed with PAD were considered to have PAD. Left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF), end-diastolic volume (EDV) and end-systolic volume (ESV) were measured. The patients were divided into CAD (-) and CAD (+) or PAD (-) and PAD (+) groups.
Results
UNASSIGNED
The prevalences of CAD and PAD in all patients were 50% and 4.8%, respectively. Age, %males, %hypertension (HTN), %dyslipidemia (DL), %diabetes mellitus (DM), %smoking and %chronic kidney disease in the CAD (+) group were significantly higher than those in the CAD (-) group. Age, %males, %HTN, %DM and %smoking in the PAD (+) group were significantly higher than those in the PAD (-) group. CAD was independently associated with LVMI (odds ratio (OR): 1.01, 95% confidence interval (CI): 1.01 - 1.02, P < 0.01) in addition to age, male, HTN, DL, DM, and smoking. PAD was also independently associated with LVMI (OR: 1.01, 95% CI: 1.0 - 1.02, P = 0.018) in addition to age, DM, and smoking.
Conclusions
UNASSIGNED
LVMI determined by CCTA may be useful for predicting atherosclerotic cardiovascular diseases including both CAD and PAD, although there were considerable differences between %CAD and %PAD in all patients.
Identifiants
pubmed: 37936626
doi: 10.14740/cr1532
pmc: PMC10627378
doi:
Types de publication
Journal Article
Langues
eng
Pagination
387-395Informations de copyright
Copyright 2023, Tachibana et al.
Déclaration de conflit d'intérêts
The authors have no conflict of interest.
Références
Am J Cardiol. 1991 Feb 1;67(4):295-9
pubmed: 1825011
J Clin Epidemiol. 2004 Mar;57(3):294-300
pubmed: 15066690
J Cardiol. 2015 Jun;65(6):487-93
pubmed: 25107604
JAMA. 2008 Jul 9;300(2):197-208
pubmed: 18612117
Heart Vessels. 2016 Jul;31(7):1061-8
pubmed: 26187325
Am J Cardiol. 2008 Nov 1;102(9):1131-5
pubmed: 18940278
Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):538-45
pubmed: 10073955
Eur Radiol. 2006 May;16(5):1117-23
pubmed: 16372162
JAMA. 2012 Oct 24;308(16):1660-7
pubmed: 23093164
Ann Intern Med. 1988 Jan;108(1):7-13
pubmed: 2962527
J Hypertens. 2007 Feb;25(2):463-9
pubmed: 17211255
Heart Vessels. 2017 Jan;32(1):30-38
pubmed: 27106918
J Cardiol. 2009 Apr;53(2):257-64
pubmed: 19304131
Hypertens Res. 2016 Mar;39(3):166-70
pubmed: 26559609
Circulation. 2004 Mar 9;109(9):1089-94
pubmed: 14993130
Circ Res. 2022 Feb 18;130(4):496-511
pubmed: 35175843
Ann Intern Med. 1989 Jan 15;110(2):101-7
pubmed: 2521199
J Am Coll Cardiol. 2004 Mar 3;43(5):840-1
pubmed: 14998626
Am J Cardiol. 1988 May 1;61(13):1130-2
pubmed: 2966554
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Heart Vessels. 2015 Nov;30(6):752-61
pubmed: 25048680
Am J Cardiol. 2022 May 15;171:84-90
pubmed: 35277254
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Am J Hypertens. 2003 Nov;16(11 Pt 1):895-9
pubmed: 14573325
BMC Cardiovasc Disord. 2007 Jan 16;7:3
pubmed: 17227586
Arch Intern Med. 2003 Apr 28;163(8):884-92
pubmed: 12719196
Circulation. 1995 Mar 1;91(5):1363-7
pubmed: 7867174
Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):166-76
pubmed: 25368207
Am J Cardiol. 2005 Sep 15;96(6):825-6
pubmed: 16169370
Arch Intern Med. 1993 Apr 26;153(8):937-42
pubmed: 8386920
Lancet. 1993 Nov 6;342(8880):1138-41
pubmed: 7901475
Eur J Radiol. 2008 Sep;67(3):481-6
pubmed: 17826936
BMJ. 1996 Dec 7;313(7070):1440-4
pubmed: 8973232